Results showed that overexpression of NURR1 could significantly increase both the total protein levels of β-catenin and also its nuclear levels of its activated form, whereas its knockdown could substantially reduce its total and nuclear levels in prostate cancer cells independent of their AR expression status (Fig. 3D, E). Here, NR4A2 is linked to prostate carcinoma.